0001493152-21-012575.txt : 20210521 0001493152-21-012575.hdr.sgml : 20210521 20210521215120 ACCESSION NUMBER: 0001493152-21-012575 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sakiris Spiro Kevin CENTRAL INDEX KEY: 0001830957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39825 FILM NUMBER: 21950946 MAIL ADDRESS: STREET 1: 708 THIRD AVENUE, 6TH FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GBS Inc. CENTRAL INDEX KEY: 0001725430 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 821512711 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 733 THIRD AVENUE STREET 2: FLOOR 15 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-790-5756 MAIL ADDRESS: STREET 1: 733 THIRD AVENUE STREET 2: FLOOR 15 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Glucose Biosensor Systems (Greater China) Holdings, Inc. DATE OF NAME CHANGE: 20171214 4 1 ownership.xml X0306 4 2021-05-19 0 0001725430 GBS Inc. GBS 0001830957 Sakiris Spiro Kevin C/O GBS, INC., 708 THIRD AVENUE, 6TH FLOOR, NEW YORK NY 10017 0 1 0 0 Chief Financial Officer Common Stock 2021-05-19 4 P 0 10000 3.066 A 16258 D /s/ Spiro Sakiris 2021-05-21